Ultrasound parameters and markers of bone turnover in hyperthyroidism: a longitudinal study

Area of Science:

• Endocrinology
• Bone Metabolism
• Medical Imaging

Background:

• Hyperthyroidism accelerates bone turnover, leading to bone mass loss.
• Graves' disease is a common cause of hyperthyroidism.
• Early assessment of bone health in hyperthyroid patients is crucial.

Purpose of the Study:

• To evaluate changes in quantitative ultrasound (QUS) parameters, bone mineral density (BMD), and bone turnover markers in hyperthyroid patients undergoing treatment.
• To assess the effectiveness of antithyroid therapy on bone health recovery.

Main Methods:

• A 2-year longitudinal study of 10 women with newly diagnosed Graves' disease receiving antithyroid therapy.
• Quantitative ultrasound (QUS) and dual-energy X-ray absorptiometry (DXA) were used to measure bone properties.
• Thyroid hormones and bone turnover markers were monitored at baseline and at 6, 12, and 24 months post-treatment.

Main Results:

• QUS parameters (Stiffness, broadband ultrasound attenuation [BUA], speed of sound [SOS]) showed significant increases after 2 years of treatment.
• Bone mineral density (BMD) of the lumbar spine and total skeleton also significantly increased.
• Bone recovery, particularly Stiffness and spine BMD, was rapid in the first year, with continued slower increments in total skeleton BMD up to 24 months.

Conclusions:

• Antithyroid therapy effectively improves bone health in hyperthyroid patients, evidenced by increased QUS parameters and BMD.
• While significant recovery is observed, complete restoration of bone health (ad integrum restitution) was not achieved within the study period.
• Long-term monitoring and potential interventions may be necessary for full bone mass recovery in these patients.